Cardiovascular diseases (CVD) such as heart attacks and strokes are leading causes of mortality worldwide. Preventing these events in high-risk individuals requires a comprehensive approach — targeting both atherosclerosis (plaque formation) and blood clot prevention.
ATOVASTRIN 40/75 is a fixed-dose combination of two powerful cardioprotective agents:
Atorvastatin 40 mg – to lower cholesterol
Aspirin 75 mg – to prevent blood clots
This combination offers dual protection by reducing the progression of arterial plaque while simultaneously preventing clot formation. Manufactured by Steris Healthcare Pvt Ltd, ATOVASTRIN AV 40/75 is an evidence-based, doctor-trusted formulation for patients requiring intensive cardiovascular risk management.
Mechanism of Action
Atorvastatin (40 mg)
A statin that inhibits HMG-CoA reductase, the key enzyme in cholesterol biosynthesis.
Lowers:
LDL (bad cholesterol)
Total cholesterol
Triglycerides
Increases:
HDL (good cholesterol)
Also offers anti-inflammatory and plaque-stabilizing benefits.
Aspirin (75 mg)
A low-dose antiplatelet agent.
Irreversibly inhibits COX-1 enzyme, thereby blocking thromboxane A2, which promotes platelet aggregation.
Prevents arterial thrombus (clot) formation, reducing the risk of heart attacks and strokes.
Uses and Indications
Aspirin and Atorvastatin Tablet Uses Include:
Secondary Prevention of Cardiovascular Events
Post-myocardial infarction (heart attack)
Post-stroke or transient ischemic attack (TIA)
Primary Prevention in High-Risk Patients
Diabetes mellitus with other risk factors
Severe hyperlipidemia and family history of CVD
Stable Coronary Artery Disease (CAD)
Reduces progression of atherosclerosis
Peripheral Arterial Disease (PAD)
Improves circulation and prevents clot-related events
Post-Angioplasty or CABG
Keeps stents and grafts patent by reducing clot formation
Efficacy and Clinical Evidence
Atorvastatin Clinical Trials:
TNT Trial (Treating to New Targets): Atorvastatin 40–80 mg reduced major cardiovascular events more than lower doses.
MIRACL Trial: Early initiation of atorvastatin post-heart attack significantly improved outcomes.
Aspirin Clinical Trials:
Antithrombotic Trialists’ Collaboration: Showed aspirin reduces the risk of serious vascular events by ~25% in high-risk patients.
ASCEND Trial: Demonstrated benefits of low-dose aspirin in diabetics for CVD prevention.
Combination Benefits:
Synergistic effect—statins reduce plaque, while aspirin prevents thrombosis.
Improved patient compliance with a single combination pill.
Side Effects and Safety Profile
Common Side Effects
Aspirin: Gastric irritation, heartburn, mild bruising
Atorvastatin: Muscle pain, headache, mild liver enzyme elevation
Less Common / Serious Side Effects
GI bleeding (due to aspirin)
Myopathy or rhabdomyolysis (rare with high-dose atorvastatin)
Liver dysfunction (monitor with periodic LFTs)
This combination should be used under medical supervision, especially in elderly or comorbid patients.
Contraindications and Precautions
Contraindications
Known allergy to aspirin or statins
Active peptic ulcer or GI bleedingBleeding disorders
Severe liver disease
Pregnancy and lactation
Precautions
Monitor for signs of GI bleeding (black stools, vomiting blood)
Regular Liver Function Tests (LFTs)
Caution in patients with renal impairment
Use gastroprotection (e.g., proton pump inhibitors) in high-risk GI patients
Drug Interactions
Aspirin Interactions:
Anticoagulants (e.g., warfarin): Increased bleeding risk
NSAIDs: Additive GI toxicity
Alcohol: Increased risk of gastric irritation
Atorvastatin Interactions:
CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole): May increase statin levels
Fibrates (e.g., gemfibrozil): Increased risk of myopathy
Grapefruit juice: Avoid large quantities
Always inform your healthcare provider about all medications and supplements.
Warnings and Regulatory Status
Warnings:
Not for use in pregnant or breastfeeding women
Monitor liver enzymes and muscle-related symptoms
Aspirin can cause Reye’s syndrome in children—avoid use under 18
Regulatory Approvals:
Approved by CDSCO (India) and other global authorities
Both components included in WHO Model List of Essential Medicines
Recommended in national and international guidelines for cardiovascular risk management
Patient Advice and Tips
Take ATOVASTRIN AV 40/75 once daily, preferably after a meal.
Do not crush or chew the tablet.
Continue even if you feel well — this is preventive therapy.
Avoid alcohol and smoking for better cardiovascular outcomes.
Inform your doctor if you experience muscle pain, dark urine, or unusual bleeding.
Periodic check-ups and lab monitoring are essential.
Frequently Asked Questions
1. What is ATOVASTRIN AV 40/75 used for?
It is used for preventing heart attacks and strokes in high-risk individuals or those with existing heart disease.
2. Can I take this tablet if I already take aspirin separately?
This combination may replace the need for separate tablets. Discuss with your doctor to avoid double-dosing.
3. How long should I take this medication?
Usually prescribed as long-term therapy. Do not stop without consulting your doctor.
4. Are there any dietary restrictions while on this medicine?
Avoid grapefruit juice and maintain a low-fat, heart-healthy diet.
5. Can I take this with blood pressure medication?
Yes, it is often taken alongside antihypertensives. However, your doctor should supervise all combinations.
Why Choose Steris Healthcare Pvt Ltd?
Steris Healthcare Pvt Ltd is a rapidly growing, quality-focused pharmaceutical company known for its clinical innovation and patient-centric formulations.
Why ATOVASTRIN AV 40/75 by Steris?
WHO-GMP certified facilities ensure international-quality manufacturing
Scientifically backed fixed-dose combinations
Consistent batch quality and bioavailability
Widely trusted by healthcare professionals
Affordable pricing to improve accessibility for chronic therapies
With Steris, patients and practitioners gain access to evidence-based, high-quality therapies that support long-term health outcomes.
Conclusion
ATOVASTRIN AV 40/75 is a powerful, dual-action formulation that combines the cholesterol-lowering benefits of Atorvastatin 40 mg with the anti-clotting protection of Aspirin 75 mg. Together, they provide comprehensive cardiovascular protection, especially for patients at high risk of heart attacks and strokes.
Manufactured by Steris Healthcare Pvt Ltd, ATOVASTRIN AV 40/75 offers a clinically proven, cost-effective, and high-quality solution in preventive cardiology. For doctors and patients seeking convenience and proven outcomes, it’s a smart therapeutic choice.
